(Worthy Insights) – Abortion advocates, their allies in the corporate media, and even the U.S. Food and Drug Administration insist the pill responsible for more than half of the nation’s abortions is “safe and effective.” A new, wide-ranging analysis of insurance claims regarding the abortion drug regimen, however, found that the rate of life-threatening complications due to mifepristone is at least 22 times higher than what the FDA and Danco Laboratories, manufacturer of mifepristone pill Mifeprex, suggest.
In the “largest known study of the abortion pill,” Ethics and Public Policy Center President Ryan Anderson and Director of Data Analysis Jamie Bryan Hall used purchased Medicaid, TRICARE, Medicare, Department of Veterans Affairs, and private medical insurance claim data to determine that 865,727 mifepristone abortion prescriptions for 692,873 women were handed out between 2017 and 2023.
Approximately 10.9 percent of those claims, or 94,605 chemical abortions, involved potentially life-threatening “serious adverse events” such as emergency room visits, hemorrhage, sepsis, infection, and/or follow-up surgeries for the women who had downed the abortion drug within the last 45 days. [ Source (Read More…) ]